Brown-Forman Corporation (BF-A)
USD 40.64
(-3.26%)
USD 40.64
(-3.26%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 647 Million | 640 Million | 936 Million | 817 Million | 724 Million | 800 Million |
| Net Income | 1.02 Billion | 783 Million | 838 Million | 903 Million | 827 Million | 835 Million |
| Depreciation & Amortization | 87 Million | 80 Million | 79 Million | 77 Million | 74 Million | 72 Million |
| Deferred income taxes | 18 Million | -3 Million | -11 Million | -53 Million | 39 Million | 34 Million |
| Stock-based compensation | 25 Million | 18 Million | 15 Million | 12 Million | 11 Million | 14 Million |
| Change in working capital | -263 Million | 410 Million | -77 Million | 28 Million | -255 Million | -163 Million |
| Other non-cash items | 16 Million | -648 Million | 92 Million | -150 Million | 28 Million | 8 Million |
| Investing Cash Flow | 49 Million | -1.35 Billion | -127 Million | 98 Million | -141 Million | -119 Million |
| Investments in PPE | -228 Million | -183 Million | -138 Million | -62 Million | -113 Million | -119 Million |
| Acquisitions | 246 Million | -1.19 Billion | - | 163 Million | -22 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 31 Million | 23 Million | 11 Million | -3 Million | -6 Million | 2 Million |
| Financing Cash Flow | -618 Million | 239 Million | -1.03 Billion | -485 Million | -191 Million | -599 Million |
| Debt repayment | -192 Million | -850 Million | -196 Million | -516 Million | -178 Million | -71 Million |
| Dividends payments | -404 Million | -378 Million | -831 Million | -338 Million | -325 Million | -310 Million |
| Common Stock Repurchased | -400 Million | - | - | - | -1 Million | -207 Million |
| Common Stock Issuance | - | - | - | - | -43 Million | -11 Million |
| Other Financing Activities | -6 Million | 1.46 Billion | -11 Million | 369 Million | 135 Million | -82 Million |
| Accounts receivables | 88 Million | -21 Million | -77 Million | -150 Million | 12 Million | 23 Million |
| Accounts payables | -31 Million | 77 Million | 37 Million | 137 Million | -30 Million | -43 Million |
| Inventory | -349 Million | -403 Million | -93 Million | -37 Million | -203 Million | -162 Million |
| Other working capital | -11 Million | 757 Million | 56 Million | 78 Million | -34 Million | 19 Million |
| Cash at beginning of period | 384 Million | 874 Million | 1.15 Billion | 675 Million | 307 Million | 239 Million |
| Cash at end of period | 446 Million | 374 Million | 874 Million | 1.15 Billion | 675 Million | 307 Million |
| Capital Expenditure | -228 Million | -183 Million | -138 Million | -62 Million | -113 Million | -119 Million |
| Effect of forex changes on cash | -6 Million | -14 Million | -47 Million | 45 Million | -24 Million | -14 Million |
| Net cash flow / Change in cash | 62 Million | -500 Million | -276 Million | 475 Million | 368 Million | 68 Million |
| Free Cash Flow | 419 Million | 457 Million | 798 Million | 755 Million | 611 Million | 681 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.02 Billion | 266 Million | 285 Million | 242 Million | 231 Million | 783 Million |
| Depreciation & Amortization | 87 Million | 21 Million | 25 Million | 20 Million | 21 Million | 80 Million |
| Deferred income taxes | 18 Million | 15 Million | 18 Million | -27 Million | 12 Million | -3 Million |
| Stock-based compensation | 25 Million | 7 Million | 7 Million | 7 Million | 4 Million | 18 Million |
| Change in working capital | -263 Million | 129 Million | 19 Million | -190 Million | -221 Million | 410 Million |
| Other non-cash items | 16 Million | 17 Million | -89 Million | 7 Million | -9 Million | -648 Million |
| Investing Cash Flow | 49 Million | -14 Million | 124 Million | -17 Million | -44 Million | -1.35 Billion |
| Investments in PPE | -228 Million | -80 Million | -69 Million | -30 Million | -49 Million | -183 Million |
| Acquisitions | 246 Million | 52 Million | 194 Million | 13 Million | - | -1.19 Billion |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 31 Million | 27 Million | 193 Million | 13 Million | 5 Million | 23 Million |
| Financing Cash Flow | -618 Million | -406 Million | -189 Million | -73 Million | 50 Million | 239 Million |
| Debt repayment | -192 Million | -300 Million | -272 Million | -67 Million | -153 Million | -850 Million |
| Dividends payments | -404 Million | -104 Million | -103 Million | -98 Million | -99 Million | -378 Million |
| Common Stock Repurchased | -400 Million | 4 Million | -358 Million | -42 Million | -4 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -6 Million | -2 Million | 272 Million | 25 Million | 153 Million | 1.46 Billion |
| Accounts receivables | 88 Million | 109 Million | 82 Million | -88 Million | -15 Million | -21 Million |
| Accounts payables | -31 Million | 38 Million | -38 Million | 22 Million | -53 Million | 77 Million |
| Inventory | -349 Million | -29 Million | 17 Million | -110 Million | -227 Million | -403 Million |
| Other working capital | -11 Million | -3 Million | -42 Million | -14 Million | 74 Million | 757 Million |
| Cash at beginning of period | 384 Million | 589 Million | 373 Million | 426 Million | 384 Million | 874 Million |
| Cash at end of period | 446 Million | 446 Million | 589 Million | 373 Million | 426 Million | 374 Million |
| Capital Expenditure | -228 Million | -80 Million | -69 Million | -30 Million | -49 Million | -183 Million |
| Effect of forex changes on cash | -6 Million | -8 Million | 9 Million | -15 Million | 8 Million | -14 Million |
| Net cash flow / Change in cash | 62 Million | -143 Million | 216 Million | -53 Million | 42 Million | -500 Million |
| Free Cash Flow | 419 Million | 205 Million | 196 Million | 29 Million | -11 Million | 457 Million |
YUEIY
GJ
ABR-PD
EN
MDDVF
MPGPF